Patent · US Expired

Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole intermediate compounds

US5387693A · kind A · utility

14Cited by
0References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 30, 1993
Grant dateFeb 7, 1995
Priority date
Expiry dateDec 30, 2013

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D231/54
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds of the general formula I: ##STR1## are disclosed as useful in the treatment or prevention of hypercholesterolemia, hyperlipoproteinemia and atherosclerosis. Novel intermediate compounds used to make the compound of formula I are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.